Cargando…
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity—Nutraceutical Options
In people with metabolic syndrome, episodic exposure of pancreatic beta cells to elevated levels of both glucose and free fatty acids (FFAs)—or glucolipotoxicity—can induce a loss of glucose-stimulated insulin secretion (GSIS). This in turn can lead to a chronic state of glucolipotoxicity and a sust...
Autores principales: | McCarty, Mark F., DiNicolantonio, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775473/ https://www.ncbi.nlm.nih.gov/pubmed/35052168 http://dx.doi.org/10.3390/healthcare10010003 |
Ejemplares similares
-
Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
por: DiNicolantonio, James J, et al.
Publicado: (2019) -
Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus
por: McCarty, Mark F., et al.
Publicado: (2020) -
Nutraceutical activation of Sirt1: a review
por: DiNicolantonio, James J, et al.
Publicado: (2022) -
Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress
por: McCarty, Mark F., et al.
Publicado: (2022) -
Nutraceutical Aid for Allergies – Strategies for Down-Regulating Mast Cell Degranulation
por: McCarty, Mark F, et al.
Publicado: (2021)